These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25204194)

  • 21. [Application of traditional Chinese medicine injections using traditional Chinese medicine theory].
    Han W; He E; Cao J
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(16):2498-500. PubMed ID: 23234156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Significance of re-evaluation and development of Chinese herbal drugs].
    Gao Y; Ma Z; Zhang B
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):1-4. PubMed ID: 22741451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Establishment of model of traditional Chinese medicine injections post-marketing safety monitoring].
    Guo XE; Zhao YB; Xie YM; Zhao LC; Li YF; Hao Z
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2974-8. PubMed ID: 24471314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research and implementation of adverse reaction automatic warning algorithm on Chinese medicine injection].
    Zhuang Y; Xie BT; Xie YM; Weng SX
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2695-7. PubMed ID: 23285911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relevance between quality craft and safe medication of Shuxuetong injection].
    Wang M; Zhang J
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2818-9. PubMed ID: 23285943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety profile of traditional Chinese herbal injection: An analysis of a spontaneous reporting system in China.
    Li H; Deng J; Deng L; Ren X; Xia J
    Pharmacoepidemiol Drug Saf; 2019 Jul; 28(7):1002-1013. PubMed ID: 31131950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-marketing safety surveillance and re-evaluation of Xueshuantong injection.
    Li C; Xu T; Zhou P; Zhang J; Guan G; Zhang H; Ling X; Li W; Meng F; Liu G; Lv L; Yuan J; Li X; Zhu M
    BMC Complement Altern Med; 2018 Oct; 18(1):277. PubMed ID: 30326892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of analysis 1 390 adverse drug reactions cases of parenterally administered dengzhan xixin based on China's spontaneous response system].
    Li YY; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2998-3002. PubMed ID: 24471319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of traditional Chinese medicine reference standards in quality control of Chinese herbal pieces].
    Lu TL; Li JC; Yu JY; Cai BC; Mao CQ; Yin FZ
    Zhongguo Zhong Yao Za Zhi; 2014 Jan; 39(1):149-52. PubMed ID: 24754185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of post marketing safety reevaluation of shenqi fuzheng injection].
    Ai QH; Li YY; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3633-6. PubMed ID: 25532410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk control system construction of Shenfu injection].
    Tian DL; Li K; Jiang JJ; Zhu YN
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2814-7. PubMed ID: 23285942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Predictive analysis on Shenmai injection-induced adverse reactions with Logistic model and ROC curve].
    Ding F; Shi QP; Jiang XD; Liu Y; Sang R; Zhu JX; Wei ST; Xin ZM; Song R
    Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(7):1404-9. PubMed ID: 26281570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research on establishment of clinical safety intensive hospital monitoring net of traditional Chinese medicine injection].
    Wang LX; Xie YM; Wang ZF
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2692-4. PubMed ID: 23285910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Technical specifications for rational clinical use of parenterally administered Chinese medicine (draft version for comments)].
    Xie YM; Li MQ; Zhang YL; Ma R; Xian SX; Liu J; Li SY; Zhao YB
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2930-2. PubMed ID: 24471306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Application status and safety countermeasures of traditional Chinese medicine injections].
    Xiong XJ; Wang J; He QY
    Zhong Xi Yi Jie He Xue Bao; 2010 Apr; 8(4):307-11. PubMed ID: 20388469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whether Metal Element-Containing Herbal Formula Angong Niuhuang Pill Is Safe for Acute Brain Disorders?
    Zhao L; Peng F; Guan B; Li X; Wu W; Chen J; Shen J
    Biol Trace Elem Res; 2015 Jul; 166(1):41-8. PubMed ID: 25829099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prospects of the development of quality control technologies for traditional Chinese medicine].
    Liang X; Feng J; Jin Y; Guo Z; Xu Q
    Se Pu; 2008 Mar; 26(2):130-5. PubMed ID: 18581842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of causes for adverse reaction of Yuxingcao injection].
    Yi Y; Liang AH; Liu T; Zhao Y; Cao CY
    Zhongguo Zhong Yao Za Zhi; 2008 Nov; 33(21):2439-42. PubMed ID: 19149243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Exploration of how to formulate guidelines on post-marketing traditional Chinese medicine surveillance].
    Zhang W; Xie YM; Yu WY
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2943-8. PubMed ID: 24471309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current state of studies on screening method for sensitinogens in injections for traditional Chinese medicine and synthetic immunity method].
    He FY; Deng KW; Zeng JL; Dai RW; Xia ZS; Liu WL; Shi JL
    Zhongguo Zhong Yao Za Zhi; 2012 Oct; 37(19):2836-41. PubMed ID: 23270218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.